ABOUT THE JOURNAL

Aims and scope of journal

The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.

Key areas of coverage include:

• Effects of genetic variability on drug toxicity and efficacy
• Identification and functional characterization of polymorphisms relevant to drug action
• Pharmacodynamic and pharmacokinetic variations and drug efficacy
• Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics
• Clinical applications of genomic science
• Identification of novel genomic targets for drug development
• Potential benefits of pharmacogenomics.

Impact Factor

Impact Factor: 4.968*

Rank:
16/205 Pharmacology & Pharmacy
20/132 Genetics & Heredity

*2007 Journal Citation Report (Thomson Reuters, 2008)

Abstracted/indexed in

BIOSIS
Biotechnology Abstracts
Cambridge Scientific Abstracts
Chemical Abstracts Service
EMBASE/Excerpta Medica
MEDLINE/Index Medicus

ISSN and eISSN

The international standard serial number (ISSN) for The Pharmacogenomics Journal is 1470-269X, and the electronic international standard serial number (eISSN) is 14763-1150.

Editors

Editor

Julio Licinio, MD

Editorial Board

J Azuma, Japan
D Flockhart, USA
P Froguel, France
L M Furness, UK
M Hashida, Japan
M Ingelman-Sundberg, Sweden
W Kalow, Canada
J Kirchheiner, Germany
T Klein, USA
C Lerman, USA
L Lesko, USA
K Lindpaintner, Switzerland
A LLerena, Spain
R Long, USA
U Meyer, Switzerland
D Nickerson, USA
L Peltonen, USA
A Rane, Sweden
M Ratain, USA
D Roden, USA
A D Roses, USA
M A Rothstein, USA
A Serretti, Italy
L Sheffield, Australia
J C Venter, USA
R Weinshilboum, USA
S Weiss, USA
R Wolf, UK
M-L Wong, USA
J Woodcock, USA